BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 29530750)

  • 1. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
    Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
    Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing plasmid transformation efficiency and enabling CRISPR-Cas9/Cpf1-based genome editing in Clostridium tyrobutyricum.
    Zhang J; Hong W; Guo L; Wang Y; Wang Y
    Biotechnol Bioeng; 2020 Sep; 117(9):2911-2917. PubMed ID: 32437010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting heterologous and endogenous CRISPR-Cas systems for genome editing in the probiotic Clostridium butyricum.
    Zhou X; Wang X; Luo H; Wang Y; Wang Y; Tu T; Qin X; Su X; Bai Y; Yao B; Huang H; Zhang J
    Biotechnol Bioeng; 2021 Jul; 118(7):2448-2459. PubMed ID: 33719068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 5. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
    Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
    Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex gene editing and large DNA fragment deletion by the CRISPR/Cpf1-RecE/T system in Corynebacterium glutamicum.
    Zhao N; Li L; Luo G; Xie S; Lin Y; Han S; Huang Y; Zheng S
    J Ind Microbiol Biotechnol; 2020 Aug; 47(8):599-608. PubMed ID: 32876764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex genome engineering in Clostridium beijerinckii NCIMB 8052 using CRISPR-Cas12a.
    Patinios C; de Vries ST; Diallo M; Lanza L; Verbrugge PLJVQ; López-Contreras AM; van der Oost J; Weusthuis RA; Kengen SWM
    Sci Rep; 2023 Jun; 13(1):10153. PubMed ID: 37349508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markerless genome editing in Clostridium beijerinckii using the CRISPR-Cpf1 system.
    Zhang J; Hong W; Zong W; Wang P; Wang Y
    J Biotechnol; 2018 Oct; 284():27-30. PubMed ID: 30081040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic process engineering of Clostridium tyrobutyricum Δack-adhE2 for enhanced n-butanol production from glucose: effects of methyl viologen on NADH availability, flux distribution, and fermentation kinetics.
    Du Y; Jiang W; Yu M; Tang IC; Yang ST
    Biotechnol Bioeng; 2015 Apr; 112(4):705-15. PubMed ID: 25363722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in n-butanol and butyrate production using engineered Clostridium tyrobutyricum.
    Bao T; Feng J; Jiang W; Fu H; Wang J; Yang ST
    World J Microbiol Biotechnol; 2020 Aug; 36(9):138. PubMed ID: 32794091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-plasmid inducible CRISPR/Cas9 genome editing tool for Clostridium acetobutylicum.
    Wasels F; Jean-Marie J; Collas F; López-Contreras AM; Lopes Ferreira N
    J Microbiol Methods; 2017 Sep; 140():5-11. PubMed ID: 28610973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different replicons in conjugative plasmids on transformation efficiency, plasmid stability, gene expression and n-butanol biosynthesis in Clostridium tyrobutyricum.
    Yu M; Du Y; Jiang W; Chang WL; Yang ST; Tang IC
    Appl Microbiol Biotechnol; 2012 Jan; 93(2):881-9. PubMed ID: 22139042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic engineering of Clostridium tyrobutyricum for n-butanol production through co-utilization of glucose and xylose.
    Yu L; Xu M; Tang IC; Yang ST
    Biotechnol Bioeng; 2015 Oct; 112(10):2134-41. PubMed ID: 25894463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic engineering of Clostridium tyrobutyricum for n-butanol production: effects of CoA transferase.
    Yu L; Zhao J; Xu M; Dong J; Varghese S; Yu M; Tang IC; Yang ST
    Appl Microbiol Biotechnol; 2015 Jun; 99(11):4917-30. PubMed ID: 25851718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling Citrate Synthase Expression by CRISPR/Cas9 Genome Editing for n-Butanol Production in Escherichia coli.
    Heo MJ; Jung HM; Um J; Lee SW; Oh MK
    ACS Synth Biol; 2017 Feb; 6(2):182-189. PubMed ID: 27700055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomics analysis of high n-butanol producing metabolically engineered Clostridium tyrobutyricum.
    Ma C; Kojima K; Xu N; Mobley J; Zhou L; Yang ST; Liu XM
    J Biotechnol; 2015 Jan; 193():108-19. PubMed ID: 25449011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous CRISPR/Cas systems for genome engineering in the acetogens
    Poulalier-Delavelle M; Baker JP; Millard J; Winzer K; Minton NP
    Front Bioeng Biotechnol; 2023; 11():1213236. PubMed ID: 37425362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic engineering of Clostridium tyrobutyricum for n-butanol production from sugarcane juice.
    Zhang J; Yu L; Xu M; Yang ST; Yan Q; Lin M; Tang IC
    Appl Microbiol Biotechnol; 2017 May; 101(10):4327-4337. PubMed ID: 28238080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas12a-Mediated Gene Deletion and Regulation in
    Zhao R; Liu Y; Zhang H; Chai C; Wang J; Jiang W; Gu Y
    ACS Synth Biol; 2019 Oct; 8(10):2270-2279. PubMed ID: 31526005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.